Add to My Stocks
$6.25 $2.15 (52.44%) MTEM stock closing price Sep 19, 2018 (Closing)
Prev Close* : $4.1
Market Cap:
Day Low: $5.85
52 Week Low: $4.00
Open: $6.41
Volume: -
Day High: $7.35
52 Week High: $13.25

Latest Stock Market News

Latest Articles

MOLECULAR TEMPL News - From Partners

MTEM Stockcharts

View MTEM PE ratio, PS ratio stocks charts and compare with peers.
MTEM Chart
Note: Compare MOLECULAR TEMPL stock price history with the index and industry peers.


PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio


(return on equity)

MOLECULAR TEMPL Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

MTEM Industry Peers

Company Price Change (%)
Tribute Pharma (TBUFF)0.930 (0%)
Rafael Holdings (RFL)9.060.14 (1.52%)
Cti Biopharma (CTIC)1.910.03 (1.6%)
Oasmia Pharma (OASM)2.750.3 (9.84%)
Newlink Genetics (NLNK)2.340.01 (0.43%)
Merck (MRK)69.980.44 (0.62%)
Pfizer (PFE)43.260.25 (0.57%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

MOLECULAR TEMPL Stock News - Partner Headlines

MOLECULAR TEMPL Financial Statements

income statement20172016201520142013
Net Sales or Revenues3.39M-76.91M14.72M12.49M
Net Income-23.14M-24.09M43.82M-21.58M-28.41M
Total Operating Expense21.23M24.35M49.98M45.97M38.51M
View MOLECULAR TEMPL income statement
balance sheet20172016201520142013
Total Assets90.39M24.28M53.66M68.39M104.11M
Total Liabilities13.1M4.39M12.82M92.37M127.59M
Shareholders Equity77.28M19.88M40.84M-23.97M-23.47M
View MOLECULAR TEMPL balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities2.09M-4.27M-72.86M-3.6M29.81M
Net Cash from (used by) Operating Activities-14.26M-25.09M-38M-27.73M10.15M
Increase (Decrease) in Prop Plant And Equipment-1.5M--0.1M53.65M5.18M
View MOLECULAR TEMPL cash flow statement

MOLECULAR TEMPL Stock Message Board

MOLECULAR TEMPL stock gained 52.44%, and the last close price as of Sep 19, 2018 is $6.25 for MTEM stock. MOLECULAR TEMPL market capitalization is $110.97M and it represents the total market value of MTEM stock. A value investor must look at the fundamentals of a stock, and perform MOLECULAR TEMPL valuation, even though in the short-term, sentiment and current breaking news might affect MOLECULAR TEMPL stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy MTEM stock than sell it, then MOLECULAR TEMPL stock price goes up. Conversely, if more investors wanted to sell MTEM stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 7,083,647 on the last trading day, as is evident from MOLECULAR TEMPL stock chart, and MTEM stock quote data. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. MOLECULAR TEMPL does not pay dividends. MOLECULAR TEMPL stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.